Baldry Mark

Baldry Mark is listed in filings as Chief Commercial Officer at X4 Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2025, including purchase activity and sale activity. Recent filings connect the profile to X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Oct 8, 2024 to Jun 3, 2025. Reported amounts are shown as $2.6K to $4.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.